Louis J Cohen
Louis J Cohen
From Past to Present: The Evolution of Pharmacologic Therapies for Eosinophilic Esophagitis [0.03%]
从过去到现在：嗜酸细胞性食管炎药物治疗的演变历程
Susie Min,Joy W Chang
Susie Min
Within the evolving landscape of eosinophilic esophagitis (EoE) management are multiple pharmacologic treatment modalities, including proton pump inhibitors (PPIs), swallowed topical corticosteroids, and novel biologic agents. Studies to da...
Laurent Peyrin-Biroulet
Laurent Peyrin-Biroulet
Overview of Metabolic Dysfunction-Associated Steatohepatitis in Children [0.03%]
儿童代谢紊乱相关性非酒精性脂肪肝病概述
Rohit Kohli
Rohit Kohli
Overcoming Challenges in Electronic Health Record Use in Inflammatory Bowel Disease Care [0.03%]
炎症性肠病护理中电子健康记录使用面临的挑战及应对措施
Hasan Saleh,Sara Horst,Jami Kinnucan
Hasan Saleh
Electronic health record (EHR) systems were introduced to enhance patient data accessibility and improve care. However, in gastroenterology, particularly in the management of inflammatory bowel disease (IBD), EHRs often place a significant ...
Gary R Lichtenstein
Gary R Lichtenstein
Ashley L Faulx
Ashley L Faulx
David Katzka
David Katzka
Kyle Staller
Kyle Staller
Enhancing the Diagnostic Yield of EGD for Diagnosis of Barrett Esophagus Through Methylated DNA Biomarker Triage [0.03%]
通过甲基化DNA生物标志物筛选提高内镜诊断巴雷特食管的阳性率
Jayde E Kurland,Sheena B Patel,Richard Englehardt et al.
Jayde E Kurland et al.
Background: EsoGuard (EG) is a methylated DNA assay for cells collected nonendoscopically with EsoCheck for detection of Barrett esophagus (BE) and can be utilized as a triage to esophagogastroduodenoscopy (EGD) in patien...